Compile Data Set for Download or QSAR
maximum 50k data
Found 59 Enz. Inhib. hit(s) with all data for entry = 7548
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200906(US9233946, 5)
Affinity DataIC50:  30nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200906(US9233946, 5)
Affinity DataIC50:  60nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200914(US9233946, 13)
Affinity DataIC50:  80nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200908(US9233946, 7)
Affinity DataIC50:  100nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200934(US9233946, 33)
Affinity DataIC50:  130nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200939(US9233946, 38)
Affinity DataIC50:  130nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200941(US9233946, 40)
Affinity DataIC50:  140nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200944(US9233946, 43)
Affinity DataIC50:  170nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM201035(US9233946, 134)
Affinity DataIC50:  180nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200939(US9233946, 38)
Affinity DataIC50:  180nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200945(US9233946, 44)
Affinity DataIC50:  200nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200916(US9233946, 15)
Affinity DataIC50:  230nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200915(US9233946, 14)
Affinity DataIC50:  280nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200940(US9233946, 39)
Affinity DataIC50:  280nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200902(US9233946, 1)
Affinity DataIC50:  280nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200926(US9233946, 25)
Affinity DataIC50:  310nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200949(US9233946, 48)
Affinity DataIC50:  360nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200917(US9233946, 16)
Affinity DataIC50:  390nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200922(US9233946, 21)
Affinity DataIC50:  420nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200943(US9233946, 42)
Affinity DataIC50:  420nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200918(US9233946, 17)
Affinity DataIC50:  450nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200928(US9233946, 27)
Affinity DataIC50:  480nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200919(US9233946, 18)
Affinity DataIC50:  510nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200959(US9233946, 58)
Affinity DataIC50:  540nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200960(US9233946, 59)
Affinity DataIC50:  560nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200974(US9233946, 73)
Affinity DataIC50:  570nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM201002(US9233946, 101)
Affinity DataIC50:  600nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200909(US9233946, 8)
Affinity DataIC50:  610nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200924(US9233946, 23)
Affinity DataIC50:  620nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM201003(US9233946, 102)
Affinity DataIC50:  660nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200925(US9233946, 24)
Affinity DataIC50:  660nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200920(US9233946, 19)
Affinity DataIC50:  720nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200910(US9233946, 9)
Affinity DataIC50:  730nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200927(US9233946, 26)
Affinity DataIC50:  750nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200911(US9233946, 10)
Affinity DataIC50:  810nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200921(US9233946, 20)
Affinity DataIC50:  850nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200912(US9233946, 11)
Affinity DataIC50:  850nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200913(US9233946, 12)
Affinity DataIC50:  1.02E+3nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200957(US9233946, 56)
Affinity DataIC50:  1.12E+3nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200961(US9233946, 60)
Affinity DataIC50:  1.30E+3nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200932(US9233946, 31)
Affinity DataIC50:  1.39E+3nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM201000(US9233946, 99)
Affinity DataIC50:  1.42E+3nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200954(US9233946, 53)
Affinity DataIC50:  1.78E+3nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200958(US9233946, 57)
Affinity DataIC50:  1.83E+3nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200962(US9233946, 61)
Affinity DataIC50:  2.24E+3nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200972(US9233946, 71)
Affinity DataIC50:  2.39E+3nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200953(US9233946, 52)
Affinity DataIC50:  2.54E+3nMAssay Description:Method A: The kinase activity of the bi-functional enzyme is readily quantified based on the production of F-2,6-P2 as described by Van Schaftingen e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200987(US9233946, 86)
Affinity DataIC50:  2.80E+3nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200981(US9233946, 80)
Affinity DataIC50:  3.10E+3nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4(Homo sapiens (Human))
Kancera

US Patent
LigandPNGBDBM200986(US9233946, 85)
Affinity DataIC50:  3.72E+3nMAssay Description:Method B: The kinase activity of the bi-functional enzyme is readily quantified based on the production of ADP and F-2,6-P2 from ATP and F6P. The ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: